DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
Claim Objections
Applicant is advised that should claim 5 be found allowable, claim 8 will be objected to under 37 CFR 1.75 as being a substantial duplicate thereof. When two claims in an application are duplicates or else are so close in content that they both cover the same thing, despite a slight difference in wording, it is proper after allowing one claim to object to the other as being a substantial duplicate of the allowed claim. See MPEP § 608.01(m).
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
(a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention.
Claim(s) 14-16 and 18 is/are rejected under 35 U.S.C. 102(a)(1) and (a)(2) as being anticipated by US 2012/0172956 A1 to Dewaegenaere (Dewaegenaere).
Regarding claim 14, Dewaegenaere teaches a thermal pad configuration (therapeutic pad 10) for placement on a patient, comprising a fluid compartment configured to receive a TTM fluid from a TTM module to facilitate thermal energy transfer between the TTM fluid and the patient ([0071] which states in part “circulating fluid to read a therapeutic pad” and [0072] which states in part “circulation of the fluid from a thermal treatment device through the connectors (202, 204) to and through the therapeutic pad (10).”) configured to receive a TTM fluid from a TTM module to facilitate thermal energy transfer between the TTM fluid and the patient and a memory chip (a readable and writeable electronic memory chip, e.g. the data storage 310) attached to the thermal pad (Fig. 7), the memory chip configured to wirelessly exchange data with a console of the TTM module ([0073-0074]).
Regarding claim 15, Dewaegenaere teaches the pad of claim 14 as well as the pad data including a status of the fluid compartment ([0056]) and the status includes one of an empty state ([0056]) or a full state.
Regarding claim 16, Dewaegenaere teaches the pad of claim 15 as well as wherein the status of the fluid compartment is changeable by logic of the console between the empty sate and the full state ([0056-0059]).
Regarding claim 18, Dewaegenaere teaches the pad of claim 14 as well as wherein the pad data include indemnification information including one or more types of thermal pad ([0047]), a model number, a size, a serial number ([0046]).
Claim Rejections - 35 USC § 103
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows:
1. Determining the scope and contents of the prior art.
2. Ascertaining the differences between the prior art and the claims at issue.
3. Resolving the level of ordinary skill in the pertinent art.
4. Considering objective evidence present in the application indicating obviousness or nonobviousness.
This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention.
Claim(s) 1-4 and 11-13 is/are rejected under 35 U.S.C. 103a as being unpatentable over Dewaegenaere in view of US 2003/0074038 A1 to Gruszecki et al. (Gruszecki).
Regarding claim 1, Dewaegenaere teaches a target temperature management (TTM) system (Fig. 7), comprising a TTM module (medical treatment device (100) configured to provide a TTM fluid ([0071]), the TTM module including a console (hardware and software user interface 104) having a processor (316) and memory (318), including a non-transitory computer-readable medium, having logic stored thereon that, when executed by the processor performs operations of the system ([0043] which states in part “a computer program product is provided. The computer program product has one or more computer readable media having computer executable instructions for performing the steps of the method…”), and a thermal pad (therapeutic pad 10) having a fluid compartment ([0071] which states in part “circulating fluid to read a therapeutic pad” and [0072] which states in part “circulation of the fluid from a thermal treatment device through the connectors (202, 204) to and through the therapeutic pad (10).”) configured to receive the TTM fluid from the TTM module to facilitate thermal energy transfer between the TTM fluid and the patient, wherein the TTM module is configured to deliver TTM fluid to the thermal pad to transition the fluid compartment from an empty state to a full state (inherent in the start of the procedure) and the thermal pad includes a memory chip (a readable and writeable electronic memory chip, e.g. the data storage 310) having stored thereon pad data including a status of the fluid compartment ([0044] which states “In a particular embodiment, the data is a medical protocol information and/or a result of a medical treatment and/or an information relating to the performance and/or lifetime of the pad.”; [0075] which states “the thermal treatment device will start writing data onto the data storage tag (310). Once the treatment stops, and the user moves to another location, the therapeutic pad (10) will be connected to a new thermal treatment device. The latter will read the information from the data storage tag (310), and by doing so it will be able to implement the right treatment protocol without needing any manual input.”; [0078] which states “Also, because the thermal treatment device will also log on the data storage tag (310) information related to the therapeutic pad (10) performance, usage, quality, etc., the thermal treatment device will be able to control and regulate the use of expired or non-performing therapeutic pads (10).”), the memory chip communicatively coupled with the console ([0073]), and the operations include exchanging pad data with the memory ship ([0073-0074]).
However, Dewaegenaere does not explicitly teach the TTM module configured to extract TTM fluid from the thermal pad to transition the fluid compartment from the full state to the empty state.
Gruszecki teaches an analogous targeted temperature management system (title “Patient Temperature Control System with Fluid Preconditioning”) including a purge mode that automatically functions to empty water from the pads ([0107]). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to have modified Dewaegenaere to include the purge mode for emptying the pad as taught by Gruszecki to allow for the thermal fluid to be removed from the device when treatment is completed or the pad needs to be disconnected as an obvious matter of engineering design choice.
Regarding claim 2, the combination teaches the system of claim 1 as well as Dewaegenaere teaching wherein the status of the fluid compartment includes at least one of the empty state ([0056]) or the full state.
Regarding claim 3, the combination teaches the system of claim 1 as well as Dewaegenaere teaching wherein the operations further include receiving the status of the fluid compartment from the memory ship ([0073-0074]).
Regarding claim 4, the combination teaches the system of claim 1 as well as Dewaegenaere teaching wherein the operations further include transmitting at least a portion of the pad data to the memory chip ([0073-0074]).
Regarding claim 11, the combination teaches the system of claim 2 as well as Dewaegenaere teaching wherein the operations include transitioning the status of the fluid compartment from the empty state to the full state ([0056-0059]).
Regarding claim 12, the combination teaches the system of claim 2 as well as Dewaegenaere teaching wherein the operations include transitioning the status of the fluid compartment from the full state to the empty state ([0056-0059]).
Regarding claim 13, the combination teaches the system according to claim 1 as well as wherein the pad data include indemnification information including one or more types of thermal pad ([0047]), a model number, a size, a serial number ([0046]).
Claim(s) 5 and 8 is/are rejected under 35 U.S.C. 103a as being unpatentable over Dewaegenaere and Gruszecki as applied to claim 1 and further in view of US 2019/0133820 A1 to Jacobsen et al. (Jacobsen).
Regarding claims 5 and 8, Dewaegenaere in view of Gruszecki teaches the system of claim 1, but not wherein the pad data includes a fluid capacity of the fluid compartment. Jacobsen teaches an analogous device (title “Devices, Systems and Methods for Endovascular Temperature Control “) that includes encoded information of the changeable components that is embedded in a chip or microchip mounted on the changeable components ([0008]), where the information includes volume of the changeable components ([0008]). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to have modified Dewaegenaere to include data related to the volume of the pad so as to provide the user with the fluid requirements of the connected components.
Claim(s) 17 is/are rejected under 35 U.S.C. 103a as being unpatentable over Dewaegenaere in view of Jacobsen.
Regarding claim 17, Dewaegenaere in view of Gruszecki teaches the pad of claim 14, but not wherein the pad data includes a fluid capacity of the fluid compartment. Jacobsen teaches an analogous device (title “Devices, Systems and Methods for Endovascular Temperature Control “) that includes encoded information of the changeable components that is embedded in a chip or microchip mounted on the changeable components ([0008]), where the information includes volume of the changeable components ([0008]). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to have modified Dewaegenaere to include data related to the volume of the pad so as to provide the user with the fluid requirements of the connected components.
Allowable Subject Matter
Claims 6, 7, 9 and 10 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims.
The following is a statement of reasons for the indication of allowable subject matter: The closest prior art as set forth above does not teach the operations as set forth in claims 6, 7, 9 and 10.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to KAITLYN E SMITH whose telephone number is (571)270-5845. The examiner can normally be reached Monday-Friday 9am-5pm.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joanne M Rodden can be reached at (303) 297-4726. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/KAITLYN E SMITH/Primary Examiner, Art Unit 3794